Therapy-related acute myeloid leukemia with KMT2A-SNX9 gene fusion associated with a hyperdiploid karyotype after hemophagocytic lymphohistiocytosis

Granfeldt Ostgard, 2015, Epidemiology and clinical significance of secondary and therapy-related acute myeloid leukemia: a national population-based cohort study, J Clin Oncol, 33, 3641, 10.1200/JCO.2014.60.0890 Henter, 2002, Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation, Blood, 100, 2367, 10.1182/blood-2002-01-0172 Pan, 2016, Acute myeloid leukemia following etoposide therapy for EBV-associated hemophagocytic lymphohistiocytosis: a case report and a brief review of the literature, BMC Pediatr, 16, 116, 10.1186/s12887-016-0649-z Ezoe, 2012, Secondary leukemia associated with the anti-cancer agent, etoposide, a topoisomerase II inhibitor, Int J Environ Res Public Health, 9, 2444, 10.3390/ijerph9072444 Molleran Lee, 2004, Characterisation of diverse PRF1 mutations leading to decreased natural killer cell activity in North American families with haemophagocytic lymphohistiocytosis, J Med Genet, 41, 137, 10.1136/jmg.2003.011528 Bergsten, 2017, Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study, Blood, 130, 2728, 10.1182/blood-2017-06-788349 Thiede, 2004, Strategies and clinical implications of chimerism diagnostics after allogeneic hematopoietic stem cell transplantation, Acta Haematol, 112, 16, 10.1159/000077555 Burmeister, 2015, Evidence-based RT-PCR methods for the detection of the 8 most common MLL aberrations in acute leukemias, Leuk Res, 39, 242, 10.1016/j.leukres.2014.11.017 Meyer, 2019, Human MLL/KMT2A gene exhibits a second breakpoint cluster region for recurrent MLL-USP2 fusions, Leukemia, 33, 2306, 10.1038/s41375-019-0451-7 Kalina, 2012, EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols, Leukemia, 26, 1986, 10.1038/leu.2012.122 McGowan-Jordan, 2016, 2016 Ammann, 2017, Primary and secondary hemophagocytic lymphohistiocytosis have different patterns of T-cell activation, differentiation and repertoire, Eur J Immunol, 47, 364, 10.1002/eji.201646686 Oguz, 2019, Secondary hemophagocytic lymphohistiocytosis in pediatric patients: a single center experience and factors that influenced patient prognosis, Pediatr Hematol Oncol, 36, 1, 10.1080/08880018.2019.1572253 Bode, 2000, Fatal connections: when DNA ends meet on the nuclear matrix, J Cell Biochem Suppl, 3, 10.1002/1097-4644(2000)79:35+<3::AID-JCB1121>3.0.CO;2-9 Hensel, 2001, Breakpoints of t(4;11) translocations in the human MLL and AF4 genes in ALL patients are preferentially clustered outside of high-affinity matrix attachment regions, J Cell Biochem, 82, 299, 10.1002/jcb.1161 Smith, 2003, Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series, Blood, 102, 43, 10.1182/blood-2002-11-3343 Meyer, 2018, The MLL recombinome of acute leukemias in 2017, Leukemia, 32, 273, 10.1038/leu.2017.213 Huret, 2013, Atlas of genetics and cytogenetics in oncology and haematology in 2013, Nucleic Acids Res, 41 Lundmark, 2003, Sorting nexin 9 participates in clathrin-mediated endocytosis through interactions with the core components, J Biol Chem, 278, 46772, 10.1074/jbc.M307334200 Buchbinder, 2014, Wiskott-Aldrich syndrome: diagnosis, current management, and emerging treatments, Appl Clin Genet, 7, 55, 10.2147/TACG.S58444 Nilson, 1996, Exon/intron structure of the human ALL-1 (MLL) gene involved in translocations to chromosomal region 11q23 and acute leukaemias, Br J Haematol, 93, 966, 10.1046/j.1365-2141.1996.d01-1748.x